1145253007: Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...
• \Product containing protein and/or protein derivative (product)\Protein-containing product\Product containing antibody (product)\Product containing monoclonal antibody (product)\Product containing brentuximab vedotin (medicinal product)\...
• \Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial
• \Brentuximab vedotin only product\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial
• \Medicinal product categorized by disposition (product)\Immunomodulator-containing product\Product containing mitotic inhibitor (product)\Microtubule inhibitor-containing product\Product containing brentuximab vedotin (medicinal product)\...
• \Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial
• \Brentuximab vedotin only product\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial
• \Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Protein-containing product\Product containing antibody (product)\Product containing monoclonal antibody (product)\Product containing brentuximab vedotin (medicinal product)\...
• \Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial
• \Brentuximab vedotin only product\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial
• \Product manufactured as parenteral dose form\Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for injection vial

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4545374012	Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4545375013	Brentuximab vedotin 50 mg powder for solution for injection vial	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4545374012	Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4545375013	Brentuximab vedotin 50 mg powder for solution for injection vial	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start